A new study reports that the physical “flexibility” of immune cells is measurably altered in people with major depressive disorder (MDD). Using mechanical tests on peripheral blood mononuclear cells (PBMCs)—a mixed population of immune cells that includes lymphocytes and monocytes—researchers found that cells from individuals with MDD deform less than those from healthy participants. The findings add a new layer to how depression may involve more than mood and cognition, potentially extending into cellular-level biophysics.
In the experiments, investigators quantified how well cells could change shape under controlled physical stress. Cell deformability is an important determinant of how immune cells navigate through tight vascular spaces, migrate to tissues, and respond to inflammation. When this mechanical property is reduced, it can, in principle, influence how efficiently cells traffic through the body and how strongly they interact with their microenvironment.
The results suggest that MDD is associated with a systemic change in cell mechanics, not merely a neural signature. While depression has long been linked to immune signaling and inflammation, mechanical alterations could represent an additional pathway by which inflammatory states or stress-related biology affect disease processes.
The study’s approach focuses on the biophysical phenotype of PBMCs. Rather than inferring immune activity indirectly, it measures how cells behave when squeezed and forced to adopt new shapes. Such direct characterization helps researchers connect psychiatric diagnosis to measurable cellular behavior.
Researchers also frame the work within the broader concept of “mechanotransduction,” where cells sense and respond to physical cues. If depressive states shift the cytoskeleton, membrane properties, or cellular stiffness, the downstream consequences could include altered immune-cell movement and altered signaling dynamics.
Notably, the work does not claim that reduced deformability alone explains depression. Instead, it proposes a reproducible cellular marker that may correlate with or contribute to the disorder’s biology. Future studies will be needed to determine whether changes in deformability track symptom severity, treatment response, or specific clinical subtypes.
The paper, published in Translational Psychiatry, is authored by Kwapich and colleagues, and appears with the DOI 10.1038/s41398-026-04225-w. By bringing rigorous cell mechanics into psychiatric research, the study opens new possibilities for biomarkers that could complement traditional clinical assessments.
Subject of Research: Major depressive disorder and immune-cell biomechanics
Article Title: Cell deformability of peripheral blood mononuclear cells is reduced in individuals with major depressive disorder.
Article References: Kwapich, L., Neckernuss, T., Geiger, D. et al. Translational Psychiatry 16, 375 (2026). https://doi.org/10.1038/s41398-026-04225-w
Image Credits: AI Generated
DOI: 10.1038/s41398-026-04225-w
